EA200400819A1 - Парентеральная композиция парацетамола - Google Patents

Парентеральная композиция парацетамола

Info

Publication number
EA200400819A1
EA200400819A1 EA200400819A EA200400819A EA200400819A1 EA 200400819 A1 EA200400819 A1 EA 200400819A1 EA 200400819 A EA200400819 A EA 200400819A EA 200400819 A EA200400819 A EA 200400819A EA 200400819 A1 EA200400819 A1 EA 200400819A1
Authority
EA
Eurasian Patent Office
Prior art keywords
paracetamol
parental composition
parental
composition
analgesic
Prior art date
Application number
EA200400819A
Other languages
English (en)
Other versions
EA006939B1 (ru
Inventor
Иоулия Цети
Original Assignee
Юни-Фарма Клеон Цетис Фармасьютикал Лэборетериз С. А.
Иоулия Цети
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Юни-Фарма Клеон Цетис Фармасьютикал Лэборетериз С. А., Иоулия Цети filed Critical Юни-Фарма Клеон Цетис Фармасьютикал Лэборетериз С. А.
Publication of EA200400819A1 publication Critical patent/EA200400819A1/ru
Publication of EA006939B1 publication Critical patent/EA006939B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение относится к фармацевтическому препарату, содержащему новый стабильный раствор парацетамола для парентерального введения, применимый с целью достижения болеутоляющего или жаропонижающего эффекта.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200400819A 2001-12-18 2001-12-18 Парентеральная композиция парацетамола EA006939B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/GR2001/000047 WO2003051398A1 (en) 2001-12-18 2001-12-18 Parenteral composition of paracetamol

Publications (2)

Publication Number Publication Date
EA200400819A1 true EA200400819A1 (ru) 2004-12-30
EA006939B1 EA006939B1 (ru) 2006-06-30

Family

ID=10927136

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200400819A EA006939B1 (ru) 2001-12-18 2001-12-18 Парентеральная композиция парацетамола

Country Status (12)

Country Link
US (1) US20050203175A1 (ru)
EP (1) EP1469885A1 (ru)
CN (1) CN1582170B (ru)
EA (1) EA006939B1 (ru)
EE (1) EE200400094A (ru)
HK (1) HK1072001A1 (ru)
HR (1) HRPK20040615B3 (ru)
HU (1) HUP0402549A3 (ru)
ME (1) ME00483B (ru)
RS (1) RS53804A (ru)
SK (1) SK2822004A3 (ru)
WO (1) WO2003051398A1 (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006346318B2 (en) 2006-07-18 2011-02-10 Genfarma Laboratorio S.L. Injectable liquid paracetamol formulation
WO2009081283A2 (en) * 2007-06-18 2009-07-02 Combino Pharm, S.L. Aqueous formulations of acetaminophen for injection
WO2009098716A2 (en) * 2008-01-17 2009-08-13 Aptuit Laurus Private Limited Stable pharmaceutical aqueous compositions
EP2243477A1 (de) 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol zur parenteralen Verabreichung
PL2277546T3 (pl) * 2009-07-23 2015-10-30 Uni Pharma Kleon Tsetis Pharmaceutical Laboratories S A Trwały, gotowy do użycia preparat paracetamolu do iniekcji
EP2308463A1 (en) * 2009-10-12 2011-04-13 EMP Pharma GmbH Aqueous acetaminophen compositions and method of preparation
EP2377514A3 (en) * 2010-04-19 2012-04-11 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Liquid parenteral formulation comprising a tramadol material and paracetamol
AU2012225268B2 (en) 2011-03-10 2016-10-20 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of peptide drugs
ES2574761T3 (es) 2011-10-31 2016-06-21 Xeris Pharmaceuticals, Inc. Formulaciones para el tratamiento de la diabetes
US9125805B2 (en) 2012-06-27 2015-09-08 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of small molecule drugs
ITMI20121154A1 (it) * 2012-06-29 2013-12-30 Sint Sa Soluzione iniettabile di acetaminofene per la somministrazione spinale
US9018162B2 (en) 2013-02-06 2015-04-28 Xeris Pharmaceuticals, Inc. Methods for rapidly treating severe hypoglycemia
AU2015300944B2 (en) 2014-08-06 2019-07-11 Xeris Pharmaceuticals, Inc. Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastes
US9649364B2 (en) 2015-09-25 2017-05-16 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic formulations in aprotic polar solvents
US11590205B2 (en) 2015-09-25 2023-02-28 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
AU2018275686B2 (en) 2017-06-02 2024-02-01 Xeris Pharmaceuticals, Inc. Precipitation resistant small molecule drug formulations

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2454424C3 (de) * 1974-11-16 1978-10-12 Messerschmitt-Boelkow-Blohm Gmbh, 8000 Muenchen Schaltung für einen elektronischen Sensor zur Auslösung einer Sicherheitsvorrichtung
GB2058562B (en) * 1979-09-14 1983-11-30 Beecham Group Ltd Pharmaceutical compositions containing paracetamol and ascorbic acid
CA2121435C (en) * 1993-04-16 2002-01-22 Sheila M. Ratnaraj Aqueous pharmaceutical suspension and process for preparation thereof
US5510389A (en) * 1994-03-02 1996-04-23 The Procter & Gamble Company Concentrated acetaminophen solution compositions
US5502056A (en) * 1994-05-27 1996-03-26 Breitbarth; Richard Caffeine containing composition
US5662353A (en) * 1995-12-06 1997-09-02 Trw Vehicle Safety Systems Inc. Electrical conductor for air bag inflator
FR2751875B1 (fr) * 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
EP0971743B1 (de) * 1997-04-18 2006-07-12 Fritz Stanislaus Stabilisiertes arzneimittel enthaltend cysteinylderivate
PT916347E (pt) * 1997-11-18 2003-07-31 Uni Pharma Kleon Tsetis A B E Solucoes farmaceuticas injectaveis contendo paracetamol e combinacoes de paracetamol com outras substancias activas
US7157103B2 (en) * 2001-08-06 2007-01-02 Euro-Celtique S.A. Pharmaceutical formulation containing irritant
ES2455195T3 (es) * 2007-11-21 2014-04-14 Dainippon Sumitomo Pharma Co., Ltd. Comprimido que se disgrega en la cavidad oral
US9072799B2 (en) * 2008-10-31 2015-07-07 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles

Also Published As

Publication number Publication date
SK2822004A3 (sk) 2005-01-03
HUP0402549A3 (en) 2006-01-30
HK1072001A1 (en) 2005-08-12
CN1582170B (zh) 2010-05-05
US20050203175A1 (en) 2005-09-15
EP1469885A1 (en) 2004-10-27
HUP0402549A2 (hu) 2005-10-28
CN1582170A (zh) 2005-02-16
HRPK20040615B3 (en) 2005-10-31
HRP20040615A2 (en) 2004-12-31
WO2003051398A8 (en) 2004-07-22
ME00483B (me) 2011-10-10
EE200400094A (et) 2004-08-16
RS53804A (en) 2006-12-15
WO2003051398A1 (en) 2003-06-26
EA006939B1 (ru) 2006-06-30

Similar Documents

Publication Publication Date Title
EA200400819A1 (ru) Парентеральная композиция парацетамола
ATE469136T1 (de) Inhibitoren von 11-beta- hydroxysteroiddehydrogenase typ 1
EA200500238A1 (ru) Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
SE0001899D0 (sv) New compounds
SE9801992D0 (sv) New 3-aryl-2-hydroxypropionic acid derivative I
EA200300172A1 (ru) Метод обезболивания
EA200300873A1 (ru) Новая соль сукцинат o-десметилвенлафаксина
EA200500239A1 (ru) Новый способ синтеза (1s)-4-,5-диметокси-1-(метиламинометил)-бензоциклобутана и его солей присоединения и применение при синтезе ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
EA200300937A1 (ru) Оральная фармацевтическая композиция цефподоксима проксетила
EA200401019A1 (ru) Дозированная лекарственная форма для перорального применения, содержащая ингибитор pde 4 в качестве действующего вещества и поливинилпирролидон в качестве вспомогательного вещества
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
NO20043367L (no) Oralt farmasoytisk preparat
EA200301223A1 (ru) Лекарственные формы окскарбазепина
CY1105847T1 (el) Γραμμικες βασικες ενωσεις που εμφανιζουν δραστικοτητα ανταγωνιστη της nk-2 και σκευασματα αυτων
TR200401436T4 (tr) Monotiyogliserol, L-sistem veya tiyoglikolik asitle birlikte pemetrexed içeren farmasötik bileşim
DE60142913D1 (de) Arzneilösungen enthaltend modafinilverbindungen
SE9904421D0 (sv) New compounds
NO20023551L (no) Ibuprofen-inneholdende aktivt middel-preparat
AR029509A1 (es) Una composicion farmaceutica en base a un compuesto de platino (iv) y el uso de dicho compuesto para preparar medicamentos antitumorales
DE60121804D1 (de) Pharmazeutische zusammensetzung eines biguanin (metformin) und arginin
EA200100540A1 (ru) Фармацевтическая композиция с модифицированным высвобождением сенсибилизатора к инсулину
EA200501046A1 (ru) Эсциталопрамгидробромид и способ его получения
EA200300727A1 (ru) Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции
ATE284878T1 (de) Pharmazeutische verbindungen mit serotonin rezeptor aktivität
EA200400707A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AZ BY KZ KG MD TJ TM

MK4A Patent expired

Designated state(s): AM RU